Physician profile
Sean C Skelton
NPI 1063592277
$4,933.14
in general payments reported to CMS, 2019-2025
24 companies · $434 in 2025
The $434 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,223 · 2020: $324 · 2021: $898 · 2022: $637 · 2023: $462 · 2024: $954 · 2025: $434.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,783 · Education: $67.46.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,782.61 |
| Education | $67.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,323.43 | 2019-2025 | Scopis Ent, Clarifix Cryotherapy Device, Audion Et Dilation System |
| Optinose US, INC. | $715.27 | 2019-2025 | |
| Genzyme Corporation | $419.84 | 2022-2024 | |
| Medtronic, INC. | $261.94 | 2023-2024 | Propel, Stealthstation S8 Platform, Pteye Parathyroid Detection System |
| Glaxosmithkline, LLC. | $247.02 | 2021-2025 | Nucala |
| Haag-Streit USA, INC. | $150.45 | 2023 | |
| Neurent Medical Limited | $126.92 | 2022-2024 | Neuromark Radiofrequency Console, Neuromark Device |
| Smith+Nephew, INC. | $102.87 | 2019-2025 | Ent Sinus, Tula |
| Regeneron Healthcare Solutions, INC. | $101.79 | 2025 | Dupixent |
| Resmed Corp | $67.46 | 2025 | |
| Hologic Sales and Service, LLC | $52.93 | 2023 | Coolseal Generator |
| Acacia Pharma INC | $49.76 | 2022 | |
| Hospira, INC. | $48.91 | 2022-2023 | |
| Intersect Ent, INC. | $47.67 | 2019-2021 | |
| Aroa Biosurgery Incorporated | $30.67 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $29.78 | 2023 | Inspire |
| Astrazeneca Pharmaceuticals LP | $28.34 | 2025 | Tezspire |
| Amgen INC. | $27.50 | 2025 | Tezspire |
| Merck Sharp & Dohme LLC | $24.77 | 2023 | |
| Pfizer INC. | $18.69 | 2025 | |
| Organogenesis INC. | $15.51 | 2025 | Puraply Wound Matrix |
| Aerin Medical INC. | $15.44 | 2020 | |
| Acera Surgical, INC. | $13.45 | 2023 | Restrata Wound Matrix |
| Ethicon US, LLC | $12.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Skelton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.